Back to search
Central Line-associated Bloodstream Infection (CLABSI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line-associated Bloodstream Infection (CLABSI) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line-associated Bloodstream Infection (CLABSI) trials you may qualify forThis is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult partici…
In recent years, with the rapid advancement of medical technology and the rapid development of critical care medicine, the use of various central venous cathete…
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on…
* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert a…
The aim of this multicenter randomized clinical trial is to compare the tunneling technique of PICC insertion with the non-tunneled insertion technique in the i…
This study aimed to evaluate the efficacy of 24-hour versus 96-hour infusion set replacement to prevent central line-associated bloodstream infection (CLABSI) i…
The goal of this clinical trial is to compare a chlorhexidine antimicrobial barrier cap in patients requiring hemodialysis treatment to the standard hemodialysi…
In a worldwide, one-day, prospective point-prevalence study, a prevalence of 15.1% for hospital-acquired central line-associated bloodstream infections (HA-CLAB…
In this research study we want to learn more about a study drug, tetrasodium sodium EDTA (Kitelock™) for maintaining the patency (blood flow) through a central…